Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer

Clinical trial NCT02057666 · TERMINATED

Trial details

NCT number: NCT02057666
Sponsor: Ipsen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms, Castration-Resistant

Start date: 2014-01-01
Primary completion: 2015-05-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.